Vetting a Supplement Contract Manufacturer

Every credible supplement contract manufacturer has a cGMP certificate on the wall. That certificate tells you a facility was inspected against a standard — it does not tell you whether this facility can run your product, on your timeline, without surprises.

The brands that launch cleanly do a little more digging before the first purchase order. Here is what that digging actually looks like, broken into four checks you can run yourself.

1. Confirm the registration, not just the certificate

A framed certificate proves the audit happened. It does not prove it is current, or that it covers the scope you need.

Ask for three things specifically:

• FDA facility registration number — verifiable, not just claimed. In the US, dietary supplement facilities must register under 21 CFR Part 207.
• The most recent third-party cGMP audit report — not the one-page certificate, but the scope summary. Which dosage forms were audited? Was softgel included, or only powders and tablets?
• Certifications relevant to your market — NSF/ANSI 455-2-A, UL, or retailer-specific audits (Costco, Wegmans, Amazon) if you are heading to those channels.

A manufacturer that hesitates to share the scope is telling you something. The scope matters because a site cleared for tablets is not automatically cleared for your softgel.

2. Audit the documentation, not the tour

Factory tours are theatre if you do not look at the paperwork behind the line. The documents that separate a real cGMP shop from a marketing brochure are:

• Master Manufacturing Record (MMR) for a product similar to yours — does it specify in-process controls, or only the final spec?
• Certificate of Analysis (COA) for a recent lot — does it test the things that matter (potency, heavy metals, microbial, identity)?
• Stability protocol and data — have they run real-time stability on the format, or only accelerated?
• Deviations and CAPA log — how do they handle an out-of-spec result? (A clean CAPA log is suspicious; a populated one with clear root-cause analysis is healthy.)
• Supplier qualification files — do they audit raw-material vendors, or only forward their COAs?

You do not need to read every page. You are checking whether the system exists and is lived in. A shop that cannot produce a recent MMR in five minutes is not running cGMP the way the certificate implies.

3. Pressure-test the capacity claim

"We can do softgels" and "we can do your softgels on your timeline" are different sentences. Capacity is the most over-claimed number in this industry.

Ask pointed questions:

• Which line will your product run on, and what else runs on that line? Shared lines mean changeover risk.
• Changeover time between products — a long changeover on a shared line quietly pushes your slot.
• Current utilisation on that line this quarter. A manufacturer at 95% utilisation will not hit your timeline, no matter what the quote says.
• Raw-material lead time for your specific actives — often the real bottleneck, and the one most likely to be glossed over.

At HiGO we would rather tell you a softgel run lands in week nine than promise week six and miss it. The number you can plan around beats the number that sounds good on the call.

4. Run a small technical call before the big PO

Before you commit volume, get the manufacturer's formulator and your formulation on the same call. Thirty minutes surfaces most of the problems that otherwise show up in sampling:

• Does the dose fit the format? (A 2-gram fibre dose does not fit a capsule.)
• Are the actives compatible, or will they react over shelf life?
• Is there a known stability concern (omega oils, hygroscopic powders) that needs early design decisions?
• What does the pilot run look like — how many samples, on what timeline, at what cost?

If a manufacturer will not put a technical person on a call before you pay for samples, that is the due-diligence answer.

The short version

• Registration — verify it, and verify the scope covers your format.
• Documentation — ask for an MMR, a recent COA, and a CAPA log. The system should be real and lived-in.
• Capacity — which line, what else runs on it, what is the real lead time this quarter.
• Technical call — get formulation and manufacturing in the room before the PO.

A contract manufacturer who welcomes these questions is one you can build a multi-year program with. One who deflects them is one you will be re-sourcing from in twelve months.

Next step: bring these four checks to your shortlist. If HiGO is on it, we will hand you the scope summary, a recent MMR, and a technical call in the same week — sales@higobiotech.com.